Skip to search boxSkip to navigationSkip to main content

Role of profibrogenic cytokines secreted by T cells in fibrotic processes in scleroderma

  • Tracy L. McGaha
    ,
  • Constantin A. Bona(corresponding author)
*Corresponding author for this work
  • Icahn School of Medicine at Mount Sinai
Scholary Output:
Contribution to journal
Review article
Peer-review

Abstract

IL-4 is potentially a major profibrogenic cytokine upregulating the expression of collagen genes. In vivo studies have shown that the disruption of STAT6, IL-4R, IL-4 or transforming growth factor-β (TGF-β) genes in TSK mice, which develop scleroderma-like syndrome, prevented the occurrence of skin sclerosis and of autoantibodies. Additionally, it is known that the homozygosity of TSK mutation is lethal and the embryos die by day 7-8 of pregnancy. The disruption of IL-4 gene rescued from death TSK/TSK mice suggesting a role for IL-4 in embryonic development. Since TGF-β should compensate the lack of IL-4 on regulation of collagen gene expression, we have studied the effect of IL-4 on the expression of TGF-β gene. Our results showed IL-4 dependence of the transcription of TGF-β gene and that in both TSK/+ and TSK/TSK IL-4-/- mice the expression of TGF-β gene is impaired.

Publication Information

Output type

Scholary Output:
Contribution to journal
Review article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 174-181 (8 pages)

Journal (Volume, Issue Number)

Autoimmunity Reviews (Volume 1, Issue 3)

Publication milestones

  • Published - 05/2002

Publication status

Published - 05/2002

ISSN

1568-9972

Publication IDs

  • Scopus: 1542614155
  • PubMed: 12849012

Publication metrics

Metrics

SciVal
FWCI
0.25
SciVal
Author count
2
SciVal
citations
25
SciVal
Paper percentile
74
Scopus
citations
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
0.50
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
29
Captures
16

Funding Details

This work was supported, in part, by NIH grant P01AI24671-14 and a grant from The Scleroderma Foundation.
FundersFunding numbers
NIH
P01AI24671-14
NIAID
P01AI024671
SF
-